Nathan D Wong Selected Research

Interleukin-6 (Interleukin 6)

12/2013	Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: cardiovascular Health Study.
3/2010	Bone mineral density and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis, Abdominal Aortic Calcium Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan D Wong Research Topics

Disease

102	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 03/2002
67	Atherosclerosis 04/2024 - 05/2003
29	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 05/2003
28	Coronary Disease (Coronary Heart Disease) 12/2022 - 03/2003
20	Hypertension (High Blood Pressure) 04/2024 - 10/2006
19	Myocardial Infarction 01/2022 - 11/2003
18	Dyslipidemias (Dyslipidemia) 02/2024 - 01/2007
18	Diabetes Mellitus 02/2023 - 09/2005
15	Type 2 Diabetes Mellitus (MODY) 09/2022 - 05/2012
13	Heart Failure 04/2024 - 02/2008
13	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 07/2006
12	Stroke (Strokes) 01/2024 - 05/2009
10	Obesity 01/2024 - 01/2007
8	Inflammation (Inflammations) 07/2021 - 01/2006
6	Hypertriglyceridemia 06/2020 - 09/2010
5	Acute Coronary Syndrome 05/2022 - 01/2019
5	Hypercholesterolemia 05/2022 - 07/2006
5	Overweight 01/2021 - 04/2011
4	Chronic Renal Insufficiency 01/2023 - 07/2015
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2022 - 04/2017
4	Death (Near-Death Experience) 01/2021 - 04/2010
4	Peripheral Arterial Disease 01/2019 - 09/2005
3	Weight Loss (Weight Reduction) 10/2023 - 04/2011
3	Hyperlipidemias (Hyperlipidemia) 02/2016 - 09/2010
3	Hypotension (Low Blood Pressure) 02/2014 - 06/2003
2	Atrial Fibrillation 04/2024 - 06/2019
2	Heart Diseases (Heart Disease) 01/2024 - 01/2023
2	COVID-19 11/2022 - 03/2020
2	Ischemic Stroke 01/2022 - 01/2015
2	Fibrosis (Cirrhosis) 01/2021 - 02/2009
2	Carotid Artery Diseases 12/2020 - 10/2014
2	Insulin Resistance 07/2020 - 11/2007
2	Atherosclerotic Plaque (Atheroma) 04/2017 - 03/2010
2	Pathologic Constriction (Stenosis) 01/2016 - 07/2010
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 06/2015 - 03/2015
2	Carotid Stenosis (Carotid Artery Stenosis) 10/2014 - 07/2014
2	Hyperglycemia 11/2013 - 01/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2007 - 08/2004
2	Chest Pain (Chest Pains) 09/2007 - 01/2007
1	Body Weight (Weight, Body) 10/2023

Drug/Important Bio-Agent (IBA)

73	CalciumIBA 04/2024 - 03/2002
39	LipidsIBA 02/2024 - 06/2003
29	oxidized low density lipoproteinIBA 04/2024 - 07/2008
29	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 03/2010
26	LDL CholesterolIBA 02/2024 - 06/2003
19	CholesterolIBA 01/2024 - 03/2005
17	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2006
14	Triglycerides (Triacylglycerol)IBA 04/2022 - 05/2003
14	HDL CholesterolIBA 01/2021 - 05/2003
13	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 05/2003
13	C-Reactive ProteinIBA 04/2022 - 03/2005
8	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 11/2003
6	Lipoprotein(a)IBA 04/2024 - 07/2016
5	HDL LipoproteinsIBA 01/2021 - 06/2003
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 02/2010
4	Lipoproteins (Lipoprotein)IBA 01/2023 - 06/2003
4	eicosapentaenoic acid ethyl esterIBA 01/2023 - 06/2020
4	omega-Chloroacetophenone (Mace)IBA 01/2021 - 04/2010
4	Hemoglobins (Hemoglobin)IBA 12/2020 - 02/2014
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2017 - 02/2008
4	Adenosine Triphosphate (ATP)IBA 10/2014 - 05/2006
3	pro-brain natriuretic peptide (1-76)IBA 04/2024 - 01/2020
3	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2023 - 09/2022
3	N(3)-(chloroacetyl)-2,3-diaminopropanoic acidIBA 04/2022 - 01/2019
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 03/2009
3	Proprotein Convertase 9IBA 01/2021 - 04/2017
3	Monoclonal AntibodiesIBA 01/2021 - 04/2017
3	Complement System Proteins (Complement)IBA 07/2020 - 03/2015
3	Ezetimibe (Zetia)FDA Link 01/2018 - 01/2015
3	Insulin (Novolin)FDA Link 11/2013 - 11/2007
3	Lisinopril (Prinivil)FDA LinkGeneric 03/2012 - 11/2003
3	Chlorthalidone (Chlortalidone)FDA LinkGeneric 03/2012 - 11/2003
3	Amlodipine (Norvasc)FDA LinkGeneric 03/2012 - 11/2003
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2022 - 09/2022
2	SodiumIBA 09/2022 - 10/2019
2	TicagrelorIBA 01/2021 - 07/2020
2	alirocumabIBA 01/2021 - 01/2019
2	Fish OilsIBA 01/2021 - 07/2020
2	HomocysteineIBA 12/2020 - 03/2010
2	Liraglutide FDA Link 12/2020 - 10/2017
2	empagliflozinIBA 07/2020 - 10/2017
2	evolocumabIBA 01/2019 - 04/2017
2	Angiotensin Receptor AntagonistsIBA 08/2017 - 01/2010
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2014 - 12/2013
2	lipoprotein cholesterolIBA 02/2014 - 10/2013
2	Interleukin-6 (Interleukin 6)IBA 12/2013 - 03/2010
2	Doxazosin (Cardura)FDA LinkGeneric 12/2012 - 11/2003
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 03/2012 - 02/2008
2	DiureticsIBA 03/2012 - 02/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2010 - 10/2008
2	ElementsIBA 01/2007 - 10/2006
1	semaglutideIBA 08/2023
1	AnticoagulantsIBA 01/2023
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023

Therapy/Procedure

43	Therapeutics 02/2024 - 03/2005
2	Precision Medicine 02/2024 - 02/2023
2	Glycemic Control 11/2022 - 08/2017
2	Continuity of Patient Care 03/2020 - 08/2017
1	Drug Therapy (Chemotherapy) 06/2023
1	Nutrition Therapy (Medical Nutrition Therapy) 01/2023